Apollomics Inc.
APLMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 14 institutions reported holding it in 13F filings for Q2 2026, worth $53.6K in total; no superinvestor holds it.
Other share classesAPLM
13F holders, Q4 2024
Institutional positions in Apollomics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −3 vs. Q3 2024
- Shares held
- 4.26M
- −418.7K (−8.9%) vs. Q3 2024
- Total value
- $39.8K
- +$6.46K (+19.4%) vs. Q3 2024
- New holders
- 0
- 3 more added
- Sold out
- 3
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLMW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $53.6K |
| Q1 2026 | 13 | $39.0K |
| Q4 2025 | 14 | $23.0K |
| Q3 2025 | 14 | $59.8K |
| Q2 2025 | 16 | $146.8K |
| Q1 2025 | 19 | $34.1K |
| Q4 2024 | 21 | $39.8K |
| Q3 2024 | 24 | $33.4K |
| Q2 2024 | 22 | $54.3K |
| Q1 2024 | 23 | $136.6K |
| Q4 2023 | 22 | $99.0K |
| Q3 2023 | 28 | $184.1K |
| Q2 2023 | 28 | $387.2K |
| Q1 2023 | 29 | $489.2K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Apollomics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 200 | $2 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 200 | $2 | 0.00% | +100+100.0% | Added |
| Ancora Advisors, LLC | 3,700 | $34 | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,799 | $127 | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 15,000 | $138 | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 41,410 | $381 | 0.00% | −342,334−89.2% | Reduced |
| Periscope Capital Inc. | 93,700 | $862 | 0.00% | 00.0% | Unchanged |
| SkyView Investment Advisors, LLC | 74,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 130,000 | $1.20K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 145,100 | $1.33K | 0.00% | +300+0.2% | Added |
| Wolverine Asset Management LLC | 167,364 | $1.54K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 244,676 | $2.27K | 0.00% | −62,572−20.4% | Reduced |
| MMCAP International Inc. SPC | 250,000 | $2.30K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 298,500 | $2.75K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 318,530 | $2.96K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 362,364 | $3.33K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 373,715 | $3.44K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 373,715 | $3.64K | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 423,293 | $3.89K | 0.00% | +207,437+96.1% | Added |
| Warberg Asset Management LLC | 436,987 | $4.02K | 0.00% | −1,800−0.4% | Reduced |
| Clear Street Derivatives LLC | 497,350 | $4.58K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,348−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,465−100.0% | Sold out |